Ignite Creation Date:
2025-12-24 @ 5:40 PM
Ignite Modification Date:
2025-12-28 @ 5:10 PM
Study NCT ID:
NCT00471068
Status:
TERMINATED
Last Update Posted:
2012-04-11
First Post:
2007-05-08
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Study of Travatan and Cosopt in Primary Open-Angle Glaucoma or Ocular Hypertension
Sponsor:
Alcon Research
Organization:
Study Overview
Official Title:
Study of Travatan and Cosopt in Primary Open-Angle Glaucoma or Ocular Hypertension
Status:
TERMINATED
Status Verified Date:
2010-02
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Question raised by Ethics Committee
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
To compare the efficacy and safety in patients treated with travoprost versus dorzolamide/timolol maleate combination in patients with open-angle glaucoma or ocular hypertension
Detailed Description:
None
Study Oversight
Has Oversight DMC:
False
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?: